Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 49 results.
User Information
Export Records
  1. 1.   Dynamic Allostery: Linkers Are Not Merely Flexible
  2. Ma, B. Y.; Tsai, C. J.; Haliloglu, T.; Nussinov, R.
  3. Structure. 2011, Jul; 19(7): 907-917.
  1. 2.   Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads
  2. Rapisarda, A.; Shoemaker, R. H.; Melillo, G.
  3. Cell Cycle. 2009, Dec; 8(24): 4040-4043.
  1. 3.   Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells
  2. Bass, S. E.; Sienkiewicz, P.; MacDonald, C. J.; Cheng, R.; Sparatore, A.; Del Soldato, P.; Roberts, D. D.; Moody, T. W.; Wink, D. A.; Yeh, G. C.
  3. Clinical Cancer Research. 2009 15(6): 1964-1972.
  1. 4.   Two Distinct Motifs within the p53 Transactivation Domain Bind to the Taz2 Domain of p300 and Are Differentially Affected by Phosphorylation
  2. Jenkins, L.; Yamaguchi, H.; Hayashi, R.; Cherry, S.; Tropea, J. E.; Miller, M.; Wlodawer, A.; Appella, E.; Mazur, S. J.
  3. Biochemistry. 2009 48(6): 1244-1255.
  1. 5.   A Negative Feedback Control of Transforming Growth Factor-beta Signaling by Glycogen Synthase Kinase 3-mediated Smad3 Linker Phosphorylation at Ser-204
  2. Millet, C.; Yamashita, M.; Heller, M.; Yu, L. R.; Veenstra, T. D.; Zhang, Y. E.
  3. Journal of Biological Chemistry. 2009 284(30): 19808-19816.
  1. 6.   IFN alpha and IFN lambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity
  2. Maher, S. G.; Sheikh, F.; Scarzello, A. J.; Romero-Weaver, A. L.; Baker, D. P.; Donnelly, R. P.; Gamero, A. M.
  3. Cancer Biology & Therapy. 2008 7(7): 1109-1115.
  1. 7.   Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
  2. Boyd, K. E.; Xiao, Y. Y.; Fan, K.; Poholek, A.; Copeland, N. G.; Jenkins, N. A.; Perkins, A. S.
  3. Blood. 2006, JAN 15; 107(2): 733-741.
  1. 8.   An estrogen receptor chimera senses ligands by nuclear translocation
  2. Martinez, E. D.; Rayasam, G. V.; Dull, A. B.; Walker, D. A.; Hager, G. L.
  3. Journal of Steroid Biochemistry and Molecular Biology. 2005, DEC; 97(4): 307-321.
  1. 9.   Evidence for the involvement of tyrosine kinase ZAP 70 in nuclear retinoid receptor-dependent transactivation in T lymphocytes
  2. Ishaq, M.; DeGray, G.; Natarajan, V.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34152-34158.
  1. 10.   A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-beta-dependent gene expression in response to interferon-gamma
  2. Roy, S. K.; Shuman, J. D.; Platanias, L. C.; Shapiro, P. S.; Reddy, S. P. M.; Johnson, P. F.; Kalvakolanu, D. V.
  3. Journal of Biological Chemistry. 2005, JUL 1; 280(26): 24462-24471.
  1. 11.   The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins
  2. Ma, B. Y.; Pan, Y. P.; Gunasekaran, K.; Keskin, O.; Venkataraghavan, R. B.; Levine, A. J.; Nussinov, R.
  3. Physical Biology. 2005, JUN; 2(2): S56-S66.
  1. 12.   SspA is required for acid resistance in stationary phase by downregulation of H-NS in Escherichia coli
  2. Hansen, A. M.; Qiu, Y.; Yeh, N.; Blattner, F. R.; Durfee, T.; Jin, D. J.
  3. Molecular Microbiology. 2005, MAY; 56(3): 719-734.
  1. 13.   Structural basis for the function of stringent starvation protein A as a transcription factor
  2. Hansen, A. M.; Gu, Y. J.; Li, M.; Andrykovitch, M.; Waugh, D. S.; Jin, D. J.; Ji, X. H.
  3. Journal of Biological Chemistry. 2005, APR 29; 280(17): 17380-17391.
  1. 14.   Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation
  2. Yamashita, M.; Ying, S. X.; Zhang, G. M.; Li, C. L.; Cheng, S. Y.; Deng, C. X.; Zhang, Y. E.
  3. Cell. 2005, APR 8; 121(1): 101-113.
  1. 15.   Comparison of the protein-protein interfaces in the p53-DNA crystal structures: Towards elucidation of the biological interface
  2. Ma, B. Y.; Pan, Y. P.; Gunasekaran, K.; Venkataraghavan, R. B.; Levine, A. J.; Nussinov, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, MAR 15; 102(11): 3988-3993.
  1. 16.   The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells
  2. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.; Gutkind, J. S.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. Anti-Cancer Drugs. 2005, FEB; 16(2): 137-143.
  1. 17.   Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1
  2. Ramakrishnan, R.; Fujimura, Y.; Zou, J. P.; Liu, F.; Lee, L.; Rao, V. N.; Reddy, E. S. P.
  3. Oncogene. 2004, SEP 16; 23(42): 7087-7094.
  1. 18.   High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B
  2. Quinto, I.; Puca, A.; Greenhouse, J.; Silvera, P.; Yalley-Ogunro, J.; Lewis, M. G.; Palmieri, C.; Trimboli, F.; Byrum, R.; Adelsberger, J.; Venzon, D.; Chen, X. N.; Scala, G.
  3. Journal of Biological Chemistry. 2004 279(3): 1720-1728.
  1. 19.   The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation
  2. Asefa, B.; Klarmann, K. D.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Keller, J. R.
  3. Blood Cells Molecules and Diseases. 2004, JAN-FEB; 32(1): 155-167.
  1. 20.   Moderate hypermutability of a transgenic lacZ reporter gene in Myc-dependent inflammation-induced plasma cell tumors in mice
  2. Felix, K.; Polack, A.; Pretsch, W.; Jackson, S. H.; Feigenbaum, L.; Bornkamm, G. W.; Janz, S.
  3. Cancer Research. 2004 64(2): 530-537.
  1. 21.   Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation
  2. Gamero, A. M.; Sakamoto, S.; Montenegro, J.; Larner, A. C.
  3. Journal of Biological Chemistry. 2004 279(13): 12379-12385.
  1. 22.   Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1
  2. Kino, T.; Pavlakis, G. N.
  3. DNA and Cell Biology. 2004 23(4): 193-205.
  1. 23.   Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction
  2. Lammerding, J.; Schulze, P. C.; Takahashi, T.; Kozlov, S.; Sullivan, T.; Kamm, R. D.; Stewart, C. L.; Lee, R. T.
  3. Journal of Clinical Investigation. 2004 113(3): 370-378.
  1. 24.   Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications
  2. Rapisarda, A.; Uranchimeg, B.; Sordet, O.; Pommier, Y.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2004 64(4): 1475-1482.
  1. 25.   Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Alley, M. C.; Hose, C.; Ciolino, H. P.; Yeh, G. C.; Trepel, J. B.; Vistica, D. T.; Sausville, E. A.
  3. Molecular Cancer Therapeutics. 2004 3(6): 715-725.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel